Clinical trial
Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in…
NCT00416507 · Federation Francophone de Cancerologie Digestive, Other · Completed
Key facts
| NCT number | NCT00416507 |
|---|---|
| Title | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery |
| Official title | Non Resectable But Non Metastatic Adenocarcinoma of the Exocrine Pancreas Non Resecables. Randomised Phase III: Initial Radiochimiotherapy (5-FU, Cisplatine, 60 GY Radiotherapy) Followed by Gemcitabine Versus Gemcitabine Alone |
| Lead sponsor | Federation Francophone de Cancerologie Digestive, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, gemcitabine hydrochloride, liposomal cisplatin |
| Enrollment | 190 |
| Start date | Mar 1, 2000 |
| Primary completion | Jul 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Dec 28, 2006 |
| Last update posted | May 30, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: